These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25430399)

  • 1. Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study.
    Behan LA; Sherlock M; Moyles P; Renshaw O; Thompson CJ; Orr C; Holte K; Salehmohamed MR; Glynn N; Tormey W; Thompson CJ
    Eur J Endocrinol; 2015 Mar; 172(3):243-50. PubMed ID: 25430399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central Diabetes Insipidus in Infancy With or Without Hypothalamic Adipsic Hypernatremia Syndrome: Early Identification and Outcome.
    Djermane A; Elmaleh M; Simon D; Poidvin A; Carel JC; Léger J
    J Clin Endocrinol Metab; 2016 Feb; 101(2):635-43. PubMed ID: 26588450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of a Standardized Sodium Protocol on Incidence and Outcome of Dysnatremias in Neurocritical Care.
    Spatenkova V; Bradac O; Skrabalek P
    J Neurol Surg A Cent Eur Neurosurg; 2015 Jul; 76(4):279-90. PubMed ID: 25539069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
    Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
    Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal regulation of thirst and vasopressin secretion following surgery for craniopharyngioma.
    Smith D; Finucane F; Phillips J; Baylis PH; Finucane J; Tormey W; Thompson CJ
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):273-9. PubMed ID: 15272926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of hypernatremic thirst deficiency with chlorpropamide.
    Nandi M; Harrington AR
    Clin Nephrol; 1978 Sep; 10(3):90-5. PubMed ID: 699408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics of 7 patients with gestational diabetes insipidus].
    Wu LQ; Xiong CQ; Wu M; Dong RL; Chen YQ; Gao J; Chen OJ; Huang YP
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):266-8. PubMed ID: 18843966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypernatraemia due to a reset osmostat for vasopressin release and thirst, complicated by nephrogenic diabetes insipidus.
    Thompson CJ; Freeman J; Record CO; Baylis PH
    Postgrad Med J; 1987 Nov; 63(745):979-82. PubMed ID: 3451225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia.
    Juul KV; Malmberg A; van der Meulen E; Walle JV; Nørgaard JP
    BJU Int; 2017 May; 119(5):776-784. PubMed ID: 27862898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential hypernatremia: disordered thirst and blood pressure control.
    Brown MA; Mullins R; Stokes GS; Györy AZ
    Aust N Z J Med; 1985 Dec; 15(6):751-4. PubMed ID: 3869442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin administration in children with central diabetes insipidus: a retrospective review.
    Ooi HL; Maguire AM; Ambler GR
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1047-52. PubMed ID: 23843580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cranial diabetes insipidus: clinical outcomes and patient perception of care.
    Dilrukshi MDSA; Vickars M; May CJH; Makaya T; Ryan F; Jafar-Mohammadi B; Wass JAH; Pal A; Garrahy A
    Eur J Endocrinol; 2022 Sep; 187(3):489-495. PubMed ID: 35900310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
    Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
    Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia.
    Christ-Crain M; Hoorn EJ; Sherlock M; Thompson CJ; Wass JAH
    Eur J Endocrinol; 2020 Jul; 183(1):G9-G15. PubMed ID: 32380474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for impaired plasma sodium homeostasis after transsphenoidal surgery.
    Staiger RD; Sarnthein J; Wiesli P; Schmid C; Bernays RL
    Br J Neurosurg; 2013 Feb; 27(1):63-8. PubMed ID: 22905890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of central diabetes insipidus.
    Garrahy A; Thompson CJ
    Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101385. PubMed ID: 32169331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical insights into adipsic diabetes insipidus: a large case series.
    Crowley RK; Sherlock M; Agha A; Smith D; Thompson CJ
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):475-82. PubMed ID: 17371462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic approach in patients with dysnatraemias.
    Liamis G; Kalogirou M; Saugos V; Elisaf M
    Nephrol Dial Transplant; 2006 Jun; 21(6):1564-9. PubMed ID: 16449285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Home monitoring of sodium in children with adipsic diabetes insipidus].
    Peinado Barraso MC; García García E
    An Pediatr (Engl Ed); 2020 Oct; 93(4):262-264. PubMed ID: 32057712
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia.
    Decaux G; Prospert F; Namias B; Soupart A
    Am J Med; 1997 Nov; 103(5):376-82. PubMed ID: 9375705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.